5P50AG005138-35 |
2019 |
$334672 |
5078 |
Core A - Administrative |
SANO, MARY |
5P50AG005138-35 |
2019 |
$413423 |
5079 |
Core B - Clinical |
GROSSMAN, HILLEL |
5P50AG005138-35 |
2019 |
$163587 |
5080 |
Core C - Data Management and Stastical |
ZHU, CAROLYN WEI |
5P50AG005138-35 |
2019 |
$218381 |
5081 |
Core D - Neuropathology |
HAROUTUNIAN, VAHRAM |
5P50AG005138-35 |
2019 |
$147571 |
5082 |
Core E - Outreach; Recruitment and Education |
SEWELL, MARAGARET |
5P50AG005138-35 |
2019 |
$149789 |
5083 |
Core - Satellite |
NEUGROSCHL, JUDITH |
5P50AG005138-35 |
2019 |
$276787 |
5084 |
Project 1: Cognitive and biological profiling of elders with diabetes |
SCHIMMING, CORBETT |
5P50AG005138-35 |
2019 |
$261942 |
5085 |
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells |
BUETTNER, CHRISTOPH |
5P50AG005138-35 |
2019 |
$245955 |
5086 |
Project 3: Effects of Type 2 Diabetes (T2D) and Alzheimer disease (AD) on angiogenesis and angiogenic complexes |
ROBAKIS, NIKOLAOS K |
5P50AG005138-34 |
2018 |
$149827 |
5082 |
Core E - Outreach, Recruitment and Education |
SEWELL, MARAGARET |
5P50AG005138-34 |
2018 |
$149869 |
5083 |
Core - Satellite |
NEUGROSCHL, JUDITH |
5P50AG005138-34 |
2018 |
$282573 |
5084 |
Project 1: Cognitive and biological profiling of elders with diabetes |
SCHIMMING, CORBETT |
5P50AG005138-34 |
2018 |
$256839 |
5085 |
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells |
BUETTNER, CHRISTOPH |
5P50AG005138-34 |
2018 |
$251176 |
5086 |
Project 3: Effects of Type 2 Diabetes (T2D) and Alzheimer disease (AD) on angiogenesis and angiogenic complexes |
YOON, YONEJUNG |
5P50AG005138-34 |
2018 |
$333949 |
5078 |
Core A - Administrative |
SANO, MARY |
5P50AG005138-34 |
2018 |
$418151 |
5079 |
Core B - Clinical |
GROSSMAN, HILLEL |
5P50AG005138-34 |
2018 |
$156841 |
5080 |
Core C - Data Management and Stastical |
LUO, XIAODONG |
5P50AG005138-34 |
2018 |
$209372 |
5081 |
Core D - Neuropathology |
HAROUTUNIAN, VAHRAM |
3P50AG005138-33S2 |
2017 |
$251341 |
None |
Administrative Supplement: Career Development in the Neuropathology of AD |
SANO, MARY |
5P50AG005138-33 |
2017 |
$124705 |
5083 |
Core - Satellite |
NEUGROSCHL, JUDITH |
5P50AG005138-33 |
2017 |
$266314 |
5078 |
Core A - Administrative |
SANO, MARY |
5P50AG005138-33 |
2017 |
$340567 |
5079 |
Core B - Clinical |
GROSSMAN, HILLEL |
5P50AG005138-33 |
2017 |
$141702 |
5080 |
Core C - Data Management and Stastical |
LUO, XIAODONG |
5P50AG005138-33 |
2017 |
$189166 |
5081 |
Core D - Neuropathology |
HAROUTUNIAN, VAHRAM |
5P50AG005138-33 |
2017 |
$121102 |
5082 |
Core E - Outreach, Recruitment and Education |
SEWELL, MARAGARET |
3P50AG005138-33S1 |
2017 |
$215840 |
None |
Core F: Genetic and Genomics |
SANO, MARY |
3P50AG005138-33S1 |
2017 |
$215840 |
7052 |
Genetics and Genomics |
GOATE, ALISON M |
5P50AG005138-33 |
2017 |
$224567 |
5084 |
Project 1: Cognitive and biological profiling of elders with diabetes |
SCHIMMING, CORBETT |
5P50AG005138-33 |
2017 |
$222303 |
5085 |
Project 2: Insulin signaling and action in the Alzheimer brain and in iPSC-derived human brain cells |
BUETTNER, CHRISTOPH |
5P50AG005138-33 |
2017 |
$200668 |
5086 |
Project 3: Effects of Type 2 Diabetes (T2D) and Alzheimer disease (AD) on angiogenesis and angiogenic complexes |
YOON, YONEJUNG |
5P50AG005138-32 |
2016 |
$1831386 |
None |
ALZHEIMER'S DISEASE RESEARCH CENTER |
SANO, MARY |
5P50AG005138-32 |
2016 |
$124708 |
5083 |
CORE - SATELLITE |
NEUGROSCHL, JUDITH |
5P50AG005138-32 |
2016 |
$267793 |
5078 |
CORE A - ADMINISTRATIVE |
SANO, MARY |
5P50AG005138-32 |
2016 |
$341326 |
5079 |
CORE B - CLINICAL |
GROSSMAN, HILLEL |
5P50AG005138-32 |
2016 |
$140562 |
5080 |
CORE C - DATA MANAGEMENT AND STASTICAL |
LUO, XIAODONG |
5P50AG005138-32 |
2016 |
$187644 |
5081 |
CORE D - NEUROPATHOLOGY |
HAROUTUNIAN, VAHRAM |
5P50AG005138-32 |
2016 |
$121469 |
5082 |
CORE E - OUTREACH, RECRUITMENT AND EDUCATION |
SEWELL, MARAGARET |
5P50AG005138-32 |
2016 |
$224926 |
5084 |
PROJECT 1: COGNITIVE AND BIOLOGICAL PROFILING OF ELDERS WITH DIABETES |
SCHIMMING, CORBETT |
5P50AG005138-32 |
2016 |
$221435 |
5085 |
PROJECT 2: INSULIN SIGNALING AND ACTION IN THE ALZHEIMER BRAIN AND IN IPSC-DERIVED HUMAN BRAIN CELLS |
BUETTNER, CHRISTOPH |
5P50AG005138-32 |
2016 |
$201523 |
5086 |
PROJECT 3: EFFECTS OF TYPE 2 DIABETES (T2D) AND ALZHEIMER DISEASE (AD) ON ANGIOGENESIS AND ANGIOGENIC COMPLEXES |
YOON, YONEJUNG |
3P50AG005138-31S1 |
2015 |
$200000 |
None |
ADMINISTRATIVE SUPPLEMENT: CAREER DEVELOPMENT IN THE NEUROPATHOLOGY OF AD |
SANO, MARY |
2P50AG005138-31 |
2015 |
$1843698 |
None |
ALZHEIMER'S DISEASE RESEARCH CENTER |
SANO, MARY |
2P50AG005138-31 |
2015 |
$222307 |
5084 |
PROJECT 1: COGNITIVE AND BIOLOGICAL PROFILING OF ELDERS WITH DIABETES |
SCHIMMING, CORBETT |
2P50AG005138-31 |
2015 |
$239680 |
5085 |
PROJECT 2: INSULIN SIGNALING AND ACTION IN THE ALZHEIMER BRAIN AND IN IPSC-DERIVED HUMAN BRAIN CELLS |
BUETTNER, CHRISTOPH |
2P50AG005138-31 |
2015 |
$200670 |
5086 |
PROJECT 3: EFFECTS OF TYPE 2 DIABETES (T2D) AND ALZHEIMER DISEASE (AD) ON ANGIOGENESIS AND ANGIOGENIC COMPLEXES |
YOON, YONEJUNG |
5P50AG005138-30 |
2014 |
$220423 |
7026 |
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EPHB |
Georgakopoulos, Anastasios |
5P50AG005138-30 |
2014 |
$249061 |
7016 |
ADMINISTRATIVE CORE |
SANO, MARY |
5P50AG005138-30 |
2014 |
$1719660 |
None |
ALZHEIMER'S DISEASE RESEARCH CENTER |
SANO, MARY |
5P50AG005138-30 |
2014 |
$254373 |
7017 |
CLINICAL CORE |
SANO, MARY |
5P50AG005138-30 |
2014 |
$144682 |
7019 |
DATA MANAGEMENT AND STATISTICS |
LUO, XIAODONG |
5P50AG005138-30 |
2014 |
$102455 |
7022 |
EDUCATION AND INFORMATION TRANSFER |
SEWELL, MARAGARET |
5P50AG005138-30 |
2014 |
$243752 |
7023 |
EVIDENCE FOR GAMMA-SECRETASE DYSFUNCTION IN SPORADIC AD |
GANDY, SAMUEL E. |
5P50AG005138-30 |
2014 |
$245953 |
7024 |
FE65-TSH-MEDIATED REGULATION OF GENE EXPRESSION IN Alzheimer's DISEASE |
SAKURAI, TAKESHI |
5P50AG005138-30 |
2014 |
$258961 |
7021 |
NEUROPATHOLOGY CORE |
PERL, DANIEL P |
5P50AG005138-29 |
2013 |
$258823 |
7016 |
ADMINISTRATIVE CORE |
SANO, MARY |
5P50AG005138-29 |
2013 |
$259413 |
7017 |
CLINICAL CORE |
SANO, MARY |
5P50AG005138-29 |
2013 |
$148166 |
7019 |
DATA MANAGEMENT AND STATISTICS |
LUO, XIAODONG |
5P50AG005138-29 |
2013 |
$104022 |
7022 |
EDUCATION AND INFORMATION TRANSFER |
SEWELL, MARAGARET |
5P50AG005138-29 |
2013 |
$249327 |
7023 |
EVIDENCE FOR GAMMA-SECRETASE DYSFUNCTION IN SPORADIC AD |
GANDY, SAMUEL E. |
5P50AG005138-29 |
2013 |
$250945 |
7024 |
FE65-TSH-MEDIATED REGULATION OF GENE EXPRESSION IN Alzheimer's DISEASE |
SAKURAI, TAKESHI |
5P50AG005138-29 |
2013 |
$264800 |
7021 |
NEUROPATHOLOGY CORE |
PERL, DANIEL P |
5P50AG005138-29 |
2013 |
$224101 |
7026 |
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EPHB |
Georgakopoulos, Anastasios |
5P50AG005138-28 |
2012 |
$277997 |
7016 |
ADMINISTRATIVE CORE |
SANO, MARY |
5P50AG005138-28 |
2012 |
$273739 |
7017 |
CLINICAL CORE |
SANO, MARY |
5P50AG005138-28 |
2012 |
$157531 |
7019 |
DATA MANAGEMENT AND STATISTICS |
LUO, XIAODONG |
5P50AG005138-28 |
2012 |
$121674 |
7022 |
EDUCATION AND INFORMATION TRANSFER |
SEWELL, MARAGARET |
5P50AG005138-28 |
2012 |
$293871 |
7023 |
EVIDENCE FOR GAMMA-SECRETASE DYSFUNCTION IN SPORADIC AD |
GANDY, SAMUEL E. |
5P50AG005138-28 |
2012 |
$295020 |
7024 |
FE65-TSH-MEDIATED REGULATION OF GENE EXPRESSION IN Alzheimer's DISEASE |
SAKURAI, TAKESHI |
5P50AG005138-28 |
2012 |
$280654 |
7021 |
NEUROPATHOLOGY CORE |
PERL, DANIEL P |
5P50AG005138-28 |
2012 |
$262132 |
7026 |
ROLE OF PS1/Y-SECRETASE IN THE ANGIOGENIC PROPERTIES OF EPHRINB/EphB |
Georgakopoulos, Anastasios |
5P50AG005138-27 |
2011 |
$1743823 |
None |
ALZHEIMER'S DISEASE RESEARCH CENTER |
SANO, MARY |
2P50AG005138-26 |
2010 |
$1781184 |
None |
ALZHEIMER'S DISEASE RESEARCH CENTER |
SANO, MARY |
5P50AG005138-25 |
2009 |
$450128 |
9003 |
CORE--CLINICAL CORE |
SANO, MARY |
5P50AG005138-25 |
2009 |
$335648 |
9002 |
CORE--NEUROPATHOLOGY CORE |
PERL, DANIEL P |
5P50AG005138-25 |
2009 |
$100747 |
9004 |
EDUCATION AND INFORMATION TRANSFER CORE |
SANO, MARY |
5P50AG005138-25 |
2009 |
$243012 |
24 |
IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP |
BUXBAUM, JOSEPH D. |
5P50AG005138-25 |
2009 |
$244472 |
28 |
PS1 REGULATES CLEAVAGE OF EPHRIN B LIGAND AND EPHB RECEPTOR |
Georgakopoulos, Anastasios |
5P50AG005138-25 |
2009 |
$242547 |
23 |
SELECTIVE NEURONAL PATHOLOGY IN THE DEVELOPMENT OF DEMENTIA |
HOF, PATRICK R |
5P50AG005138-25 |
2009 |
$122842 |
9005 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
HAROUTUNIAN, VAHRAM |
5P50AG005138-24 |
2008 |
$98052 |
9004 |
EDUCATION AND INFORMATION TRANSFER CORE |
SANO, MARY |
5P50AG005138-24 |
2008 |
$237088 |
24 |
IDENTIFICATION AND CHARACTERIZATION OF FIRST MESSENGERS THAT REGULATE APP |
BUXBAUM, JOSEPH D. |
5P50AG005138-24 |
2008 |
$438092 |
9003 |
CORE--CLINICAL CORE |
SANO, MARY |
5P50AG005138-24 |
2008 |
$237932 |
28 |
PS1 REGULATES CLEAVAGE OF EPHRIN B LIGAND AND EPHB RECEPTOR |
Georgakopoulos, Anastasios |
5P50AG005138-24 |
2008 |
$236631 |
23 |
SELECTIVE NEURONAL PATHOLOGY IN THE DEVELOPMENT OF DEMENTIA |
HOF, PATRICK R |